Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > 99% up by HPLC, S. Impurity ≤0.05% Vortioxetine Hydrobromide 960203-27-4
99% up by HPLC, S. Impurity ≤0.05% Vortioxetine Hydrobromide 960203-27-4
单价 面议对比
询价 暂无
发货 全国
过期 长期有效
更新 2025-08-13 22:05
 
详细信息

Grade: Pharmaceutical Grade

Factory Location: Xiamen

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Monthly Production Capacity: 10tons/year

Contract Manufacturing: CRO,CMO

Packaging Information: 25kg/bag

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/C

Product Information

 

Product name

Vortioxetine Hydrobromide;

Vortioxetine HBr

CAS No.

960203-27-4

Molecular Formula

C18H23BrN2S

Molecular Weight

379.364

Quality Standard

99% up by HPLC, S. Impurity ≤0.05% 

Appearance

White to light yellow crystalline powder

 

COA

 

ANALYSIS

SPECIFICATION

RESULTS

Appearance

White to light yellow crystalline powder

White crystalline powder

Identification(HPLC)

Similar retention time for sample and  reference solution peak.

Conforms

Identification(IR)

Complies with reference spectrum

Conforms

Bromide

Bromide identification Positive reaction.

Conforms

Related substance

(HPLC, %area)

Unspecified lmpurities not more than 0.05%

<0.02%

Total lmpurities not more than 0.10%

<0.02%

Conclusion

The sample complies with the Specifications.

 

Usage

 

The function of Vortioxetine hydrobromide is as follows:

1.     Antidepressant: Vortioxetine hydrobromide is a novel antidepressant with a multimodal mechanism of action that comprehensively improves depressive symptoms, including emotional, physical, and cognitive aspects. It has been shown to be effective in treating major depressive disorder (MDD), depression with severe anxiety, generalized anxiety disorder (GAD), and for patients who have failed to respond to treatment with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).

2.     Reducing the Risk of Disease Recurrence: In addition to directly improving depressive symptoms, vortioxetine hydrobromide can also reduce the risk of disease recurrence, helping patients stabilize their mood and minimize disease fluctuations.

3.     Improving Daily Social Functioning and Cognitive Function: While improving depressive symptoms, vortioxetine hydrobromide can also enhance patients' daily social functioning and cognitive function, enabling them to better integrate into society and improve their quality of life.

4.     Multiple Mechanisms of Action: Vortioxetine hydrobromide modulates the activity of multiple serotonin receptors in the brain, which play crucial roles in regulating mood, cognitive function, and overall mental health. By balancing neurotransmitters, vortioxetine hydrobromide helps restore mood and improve depressive symptoms and cognitive function.

5.     High Safety: Compared to traditional antidepressants, vortioxetine hydrobromide has a lower incidence of adverse events and a higher safety profile.